Lead sponsor
Tuscaloosa Research & Education Advancement Corporation
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
0
Ongoing
20
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 3
1
Trials by status
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With DementiaMultiple dementia etiologiesPh 3Terminated20